Japan’s Fuji Dream Airlines (FDA) has signed a firm order with Embraer for two E175 jets. The order has a value of $97.2 million, based on 2019 list prices.
“We are extremely pleased to continuously grow our fleet and our relationship with Embraer,” said Yohei Suzuki, Chairman and CEO of Fuji Dream Airlines. “FDA currently operates 14 aircraft - three E170s and eleven E175s. These new aircraft will give us the ability to grow our capacity, allowing us to add more routes and frequencies, while also offering our passengers the best cabin in its category.”
FDA’s new E175s will be configured in a single-class layout with 84 seats, with deliveries starting this year. Embraer delivered the first E-Jet, an E170, to Fuji Dream Airlines in 2009.
“After nearly 10 years of operations, Fuji Dream Airlines has established itself as an exemplary model for sustainable growth with the support of the E175’s unrivaled attributes underpinning the success of their continued network expansion with new point-to-point services,” said Cesar Pereira, Asia Pacific Vice President, Embraer Commercial Aviation. “As a testament to Embraer’s merits, there will be a total of 48 E-Jets flying in Japan by the end of 2019. Of which, FDA's all-Embraer fleet of 14 aircraft represents the largest of its kind in Asia and has a world leading 99.83% dispatch reliability - yet another example of how Embraer's products and customer support have been setting new standards in the industry.”
FDA and Embraer have also signed an extension of the Pool Program to cover its fleet of E170s and E175s, including these new orders. The program includes the advance exchange and repair management for more than 300 essential line replacement units of the aircraft.© Asia Travel Tips